| α-Gal A | Alpha-galactosidase A |
| AUC | Area under the curve |
| ERT | Enzyme replacement therapy |
| FDCM | Fabry disease cardiomyopathy |
| FSL | Function–spacer–lipid |
| GB3 | Globotriaosylceramide |
| MSD | Meso Scale Discovery |
| ROC | Receiver-operating characteristics |
| α-Gal A | Alpha-galactosidase A |
| AUC | Area under the curve |
| ERT | Enzyme replacement therapy |
| FDCM | Fabry disease cardiomyopathy |
| FSL | Function–spacer–lipid |
| GB3 | Globotriaosylceramide |
| MSD | Meso Scale Discovery |
| ROC | Receiver-operating characteristics |